Vivek Ramaswamy’s brother Shankar raises $1.2 billion for gene therapy firm with no successful results: 'Another pump-and-dump'

Kriya Therapeutics, a gene therapy company founded in 2019 by Shankar Ramaswamy, brother of GOP leader Vivek Ramaswamy, has raised more than $1.2 billion in funding without any approved products, according to funding trackers and reports from Labiotech.eu and BioPharma Dive.Its latest boost came in September 2025, when it secured a $320 million oversubscribed Series D round co-led by Premji Invest and Patient Square Capital. Earlier rounds, including $313 million raised earlier in 2025 and prior Series A, B, and C rounds, pushed total funding beyond $1.2 billion. However, the sudden surge in financing raised questions as the company had no products approved by regulators.